GRx+Biosims 2019
November 1, 2019
The Association for Accessible Medicines (AAM) and its Biosimilars Council are eager for the start of GRx+Biosims 2019 beginning Monday, November 4.
Biosimilars Council - Renegotiated NAFTA Event
September 12, 2018
Please join the Association for Accessible Medicines (AAM) for a briefing to discuss the proposed NAFTA agreement, its impact on rising prescription drug prices and recommendations for a stronger agreement.
The Biosimilars Council - Seniors Sitting at a Meeting
July 26, 2018
A lunch briefing hosted by the Association for Accessible Medicines (AAM) and its Biosimilars Council to learn more about the promise that biosimilars offer to patients and the health care system, and the challenges to the nascent market.
The Biosimilars Council - GRxBiosims Event Banner
April 4, 2018
GRx+Biosims is the name of the combined event that replaces FallTech, Leading on Biosimilars and CMC Workshop. The program will be comprehensive and the speakers are the top in their field. Whatever your interests, you will find what you need at GRx+Biosims.
The Biosimilars Council - People Meeting Image
April 4, 2018
Join The Biosimilars Council and the Association for Accessible Medicines for cocktails and networking with other women in health policy. This nonpartisan event will be an opportunity to reconnect with old colleagues and meet new ones.
March 1, 2017
The Atlantic gathered key stakeholders to examine the emerging world of biosimilars and their regulatory framework in the United States. How does the Food and Drug Administration implement the biosimilar approval pathway? Do biosimilar drugs require the same clinical trials as the biologics on which they are modeled? How will the process impact access and affordability, and what does it mean for innovation?

Recent Tweets

Did you know the Biosimilars Council has a newsletter that includes the latest updates in the #biosimilars industry including policy movement, educational resources and upcoming events?

Subscribe to receive the Biosimilars Bulletin today:

Load More...